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Abstract
Chimeras composed of the cdtB gene of a novel bacterial genotoxin and the human type I
deoxyribonuclease (DNase I) gene were constructed and their products characterized relative to
the biochemical and enzymatic properties of the native proteins. The product of a cdtB/DNase I
chimera formed a heterotrimer with the CdtA and CdtC subunits of the genotoxin and targeted
mutations increased the specific activity of the hybrid protein. Expression of active chimeric gene
products established that the CdtB protein is an atypical divalent cation-dependent endonuclease
and demonstrated the potential for genetically engineering a new class of therapeutic agent for
inhibiting the proliferation of cancer cells.
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Introduction
The human periodontal bacterium Aggregatibacter actinomycetemcomitans is among a
small group of facultative or microaerophilic gram-negative pathogenic bacterial species
that produce a genotoxin, known as the cytolethal distending toxin (Cdt), that inhibits the
proliferation of certain types of eukaryotic cells. Oral cells of epithelial origin appear to be
natural targets (Kang et al., 2005; Kanno et al., 2005). The Cdt is a heterotrimer that has a
structural organization exemplified by A-B-type toxins (Spangler, 1992). Two heterogenous
subunits, CdtA and CdtC, promote binding of the toxin to the cell surface by forming a
lectin-like groove analogous to that found in homodimers of the B chain of ricin (Nešić &
Stebbins, 2005). Deduced amino acid sequences of various CdtB subunits exhibit a weak
phylogenetic relationship to the large superfamily represented by endonucleases,
exonucleases, sphingomyelinases and inositol polyphosphate 5-phosphatases (Hofmann et
al., 2000). It has been reported that CdtB from Escherichia coli (Elwell & Dreyfus, 2000),
Helicobacter hepaticus (Dassanayake et al., 2005) and A. actinomycetemcomitans (Mao &
DiRienzo, 2002) exhibits in vitro double-strand DNA nicking activity.
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Cdt-susceptible cell types or lines only respond to the heterotrimer. The exact sequence of
events and roles of the subunits during the cell intoxication process have not been fully
elucidated. However, studies to date suggest that the Cdt binds to either a fucose-containing
glycoprotein (McSweeney & Dreyfus, 2005) or ganglioside (Mise et al., 2005) on the cell
surface and the CdtB subunit, either alone or with CdtC, enters the cell through the Golgi
complex (Guerra et al., 2005) or by an endosomal pathway (Akifusa et al., 2005). The CdtB
subunit is translocated to the nucleus and crosses the nuclear membrane with the aid of a
nuclear localization sequence (Nishikubo et al., 2003; McSweeney & Dreyfus, 2004). In
some sensitive cell types chromatin damage occurs as double-strand breaks (Frisan et al.,
2003; Kanno et al., 2005). The unrepaired DNA damage is thought to signal the cell to arrest
cell cycle progression due to the accumulation of checkpoint proteins (Escalas et al., 2000).
The location of the cell cycle block is cell type or line dependent. It has been proposed in
one study that human lymphocytes undergo cell cycle arrest and apoptosis in response to the
A. actinomycetemcomitans CdtB protein through a signaling pathway involving
phosphatidylinositol 3,4,5-triphosphate phosphatase activity (Shenker et al., 2007).
The ability of CdtB to (i) exhibit in vitro DNA nicking activity, (ii) induce DNA damage in
some cell types or lines and (iii) display a tentative phylogenetic relationship to Mg2+dependent phosphohydrolases invites a more detailed comparison of the relationship
between these prokaryotic and eukaryotic proteins. A well characterized example of a Mg2+dependent endonuclease is mammalian DNase I which functions as a digestive enzyme
(Lacks, 1981). In this study we compared the biochemical properties of CdtB and DNase I
and then used this information to characterize the products of chimeras composed of the A.
actinomycetemcomitans cdtB and human DNase I genes. Analysis of hybrid proteins
provides insight into the relationship between CdtB and DNase I beyond that obtained from
the study of the native proteins alone. The implications of this relationship are discussed in
view of the role of the CdtB subunit in cytotoxicity and in engineering inhibitory agents for
certain types of cancer cells of epitheloid origin.

Materials and methods
Construction of chimeric cdtB genes
Plasmids and primers used in this study are listed in Tables 1 and 2, respectively. All PCR
and restriction digestion reactions were performed using standard techniques. Restriction
endonucleases were purchased from New England Biolabs (Beverly, MA) and PCR
oligonucleotide primers were obtained from Integrated DNA Technologies (IDT, Coralville,
IA). Constructs were first selected in E. coli DH5α [supE44 ΔlacU169 (φ80lacZΔM15)
hsdR17 recA1 endA1 gyrA96 thi-1 relA1] and transformed into E. coli BL-21(DE3) for
gene expression analysis and isolation of the gene product. Bacteria were grown in LB broth
containing 75 μg/ml ampicillin at 37°C with vigorous shaking. Plasmid DNA was isolated
using either a QIAprep Miniprep (QIAGEN, Valencia, CA) or the Wizard Miniprep Kit
(Promega Corporation, Fitchburg, WI). All constructs and mutations were confirmed by
DNA sequencing. Automated cycle sequencing reactions were conducted by the DNA
Sequencing Facility at the University of Pennsylvania Abramson Cancer Center using an
Applied Biosystems 96-capillary 3730XL sequencer with BigDye Taq FS Terminator V 3.1.
The cdtB gene sequence used throughout these experiments was from construct pJDB7
originally made in Cao et al., (2005) and based on the sequence deposited in GenBank
(accession no. AF006830). The full length DNase I sequence (GenBank accession no.
AC005203) was amplified from plasmid GC-C0001 (GeneCopoeia, Inc., Germantown, MD)
using the PCR primers N-DNase-F and X-DNase-R. This amplicon was cloned, in frame, to
the His-tag in pETBlue2 (EMD Chemicals-Novagen, San Diego, CA) using NcoI and XhoI
restriction endonuclease cleavage sites. Portions of the DNA sequence from the resulting
FEMS Microbiol Lett. Author manuscript; available in PMC 2012 December 17.
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clone, pJD1, were used to construct the chimeras. To construct the DNase I/cdtB gene
chimera the 5'-half of the DNase I gene sequence was obtained by digestion of pJD1 with
NcoI and SphI, the 3'-half of the cdtB gene was obtained by digesting pJDB7 with SphI and
BamHI and pET15b was cut with NcoI and BamHI. The three DNA fragments were ligated
to obtain pETDB1 (Table 1). To construct the cdtB/DNase I gene chimera the PCR primers
N-cdtB-F and S-cdtB-R were used to amplify the 5'-half of cdtB using pJDB7 as the
template DNA. pJD1 was digested with NcoI and SphI and the large DNA fragment was
ligated to the pJDB7 amplicon after digestion with the same enzymes (clone pBDN1). The
insert DNA fragment from pBDN1 was amplified using the PCR primers N-cdtB-F and
NdeI-His and the amplicon was cloned into the NcoI and NdeI sites of pET15b. The
resulting plasmid, pETBDN2, contained the cdtB/DNase I chimeric gene, with codons for a
His-tag at the 3'-end, in the same vector background as the DNase I/cdtB gene chimera.
Amino acid substitutions mutants
Amino acid substitutions were made in the CdtB/DNase I hybrid protein by site-directed
mutagenesis as described previously (Cao et al., 2006). Synthetic oligonucleotide primer
pairs were used to change S99Y and R100E (both in same primer), L62E, G55R and
V134R. Briefly, mutant DNA strands were made using PfuUltra DNA polymerase
(Stratagene, La Jolla, CA) in PCR. Plasmid DNA from pETBDN2 was used as the first PCR
template. Additional mutations were then made sequentially using plasmid DNA from
pETBDN2–1 to pETBDN2–5. Methylated parental DNA strands were digested with DpnI
and the intact mutated DNA strand was transformed into E. coli TOP10 [F− mcrAΔ(mrrhsdRMS-mcrBC) φ80lacZΔM15ΔlacX74 recA1 araD139Δ(ara-leu)7697 galU galK
rpsL(strR) endA1 nupG] chemically competent cells (Invitrogen, Carlsbad, CA). The
mutations were confirmed by sequencing of the plasmid insert DNA from a single
transformant.
The same strategy was used to change the active site H160 in CdtB-His6 to Ala. DNA from
pJDB7 was used as the PCR template for primers H160for and H160rev. The mutated
protein from this clone was used as a negative activity control in the bioassays.
The large loop domain was added to CdtB/DNase I using an inverse PCR method (Cao et
al., 2004) with the Loop-F and Loop-R primers (Table 2) and the insert fragment from
pETBDN2–5 (Table 1), containing the cdtB/DNase I nucleotide sequence, as the template
DNA. Codons for LMLNQLRSQIT replaced NGLSDQLAQAI in pETBDN2-5LL.
Isolation of gene products and heterotoxin reconstitution

Escherichia coli BL-21(DE3) [F− ompT hsdSB (rB− mB−) gal dcm (DE3)] (Novagen)
containing pJDA9 (wild-type CdtA-His6), pJDC2 (wild-type CdtC-His6), pJDB7 (wild-type
CdtB-His6), pMUT160cdtB (active site mutant), pETBDN2 (cdB-DNase I chimera),
pETDNB1 (DNase I-cdB chimera) and pETBDN2–1 to pETBDN2–5(cdB-DNase I mutated
chimera) were used to isolate gene products by affinity chromatography on nickeliminodiacetic acid columns (Novagen) as described previously (Cao et al., 2005). All of the
gene products have a His6–7 tag at the carboxy-terminal end. The final protein preparations
were dialyzed to remove urea, passed through 45 micron filters and quantified with the
Micro BCA protein assay kit (Pierce, Rockville, IL). Purity was assessed by analysis on 10–
20% polyacrylamide gels. The presence of the His-tag on all protein constructs was verified
by western blotting using Anti-His•Tag Monoclonal Antibody (Novagen). Aliquots of the
quantified protein samples were stored at −70°C in a buffer containing 10 mM Tris-HCl (pH
7), 100 mM NaCl, 5 mM MgCl2 and 5 mM imidazole for use in the various bioassays. Wildtype heterotoxin and heterotoxin containing hybrid and mutated hybrid proteins were
reconstituted as described previously (Mao & DiRienzo, 2002). Attempts to purify
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recombinant human DNase I from either E. coli BL-21(DE3) (pJD1) or E. coli BL-21(DE3)
(pETDN1) were unsuccessful most likely due to the poor expression of the human DNase I
gene in E. coli as noted by Linardou et al. (2000).
In vitro DNase activity
Supercoiled DNA nicking activity was determined, with minor modifications, as described
previously (Elwell & Dreyfus, 2000; Mao & DiRienzo, 2000). In a typical assay 1 μg of
supercoiled pBluescript II SK(+) DNA (Sigma-Aldrich, St. Louis, MO) was incubated with
1 μg of wild-type, mutant or hybrid CdtB protein in 25 mM HEPES (Sigma-Aldrich) (pH
7.0) containing 50 mM MgCl2 at 37°C for 1 h. DNase I (0.1 ng), from bovine pancreas
(Sigma-Aldrich), was used in place of human DNase I. Bovine DNase I is approximately
2.4-fold more active than the human homolog (Pan et al., 1998). Each form of DNA
(supercoiled, relaxed, linear) was quantified and compared using ImageJ version 1.34
(http://rsb.info.nih.gov/ij/) and digitized images of ethidium bromide-stained gels. Protein
and divalent cation concentrations were varied in some kinetic and biochemical analyses.
Heat lability was compared by pretreating proteins at 100°C for up to 30 min prior to
determining DNA nicking activity. Actin inhibition of DNA nicking activity was performed
essentially as described by Ulmer et al, (1996). Rabbit skeletal muscle G-actin (SigmaAldrich) was de-polymerized at room temperature for 15 min in a buffer containing 25 mM
HEPES (pH 7.5), 5 mM CaCl2, 5 mM MgCl2, 0.1%BSA, 0.05% Tween 20 and 0.5 mM 2mecaptoethanol. Five micrograms of the depolymerized G-actin were preincubated with 1
μg of CdtB-His6 or 0.1 ng of bovine DNase I for 60 min at 37°C. The treated proteins were
then examined in the nicking assay. Subunit protection of DNA nicking activity was
assessed as described previously (Nešić et al., 2004) except that incubation was performed at
room temperature for 1 hour.
In vivo CdtB activity
Cell proliferation was measured with a colony-forming assay employing CHO cells [300
cells in 3 ml of medium per well (6-well plate) in triplicate] as described in Mao &
DiRienzo (2002). The number of colonies per well was expressed as colony-forming units
(CFU). A dose response curve for wild-type reconstituted heterotoxin has been published
(Cao et al., 2005). Cell cycle arrest was determined by flow cytometry of propidium iodide
stained nuclei as described previously (Cao et al., 2005).
Binding kinetics
Saturation kinetics were used to assess binding of the hybrid and mutated hybrid proteins to
wild-type CdtA-His6 and CdtC-His6 in a thyroglobulin ELISA (Cao et al., 2005). Wild-type
CdtA-His6 (4.0 μg) and CdtC-His6 (3.5 μg) were added to thyroglobulin-coated wells.
Hybrid or mutated hybrid protein (0–4 μg) was then added to triplicate wells. Bound protein
was detected with a 1 × 10−6 dilution of anti-CdtB IgG rabbit antiserum and a 1 × 10−3
dilution of donkey anti-rabbit IgG-horseradish peroxidase conjugate (Amersham Pharmacia
Biotech, Piscataway, NJ) (Cao et al., 2008). The ability of the hybrid and mutated hybrid
proteins to bind the other subunits was also determined by stoichiometric binding in the
thyroglobulin ELISA as described previously (Cao et al., 2005). Wild-type CdtA-His6 was
prebound to thyroglobulin-coated 96-well microtiter plates as described above. Hybrid and
mutated hybrid proteins (4.5 μg) and wild-type CdtC-His6 (3.5 μg) were added to triplicate
wells. Total bound protein was detected with anti-His•Tag monoclonal antibody and antimouse IgG horseradish peroxidase conjugate both at a 1 × 10− dilution. An absorbance ratio
of 3.0 is indicative of the binding of the hybrid or mutated hybrid protein to the other two
subunits. CdtB-His6 and DNase I do not bind to thyroglobulin. ELISA plates were washed
in a BioTek Model EL405 HT microplate washer (BioTek Instruments, Inc., Winooski, VT).
FEMS Microbiol Lett. Author manuscript; available in PMC 2012 December 17.
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Absorbance values were obtained with a BioTek Synergy 2 Multi-Detection Microplate
Reader.
Differential dialysis was performed as described previously using dialysis membrane with a
molecular weight exclusion limit of 100 kDa (Spectrum Laboratories, Inc., Rancho
Dominguez, CA) (Cao et al., 2008). Immunopositive bands on western blots were quantified
with ImageJ.
Computer modeling
The European Molecular Biology Open Software Suite (EMBOSS release 3.0; http://
emboss.sourceforge.net) (Rice et al., 2000) was used to obtain the deduced amino acid
sequences for cdtB-His6 (from pJDB7), cdtB/DNase I, DNase I/cdtB and human DNase I
(from pETDN1) and to create the alignment using ClustalX 1.83. The crystal structures of
the A. actinomycetemcomitans Y4 Cdt (Yamada et al., 2006) and bovine DNase I were
modeled with UCSF Chimera 1.2197 (http://www.cgl.ucsf.edu/chimera/) (Pettersen et al.,
2004). Coordinates were obtained from the Protein Data Bank (accession nos. 2F2F and
3DNI, respectively). Human DNase I has not been crystalized. CdtB/DNase I and DNase I/
CdtB structures were predicted using Modeller version 9v1 (http://salilab.org/modeller/)
(Marti-Renom et al., 2000).

Results
Kinetic analysis of CdtB-His6 and DNase I
Purified recombinant A. actinomycetemcomitans Y4 CdtB from pJDB7 (Fig. 1a), converted
supercoiled [superhelical (S) circular, Form I] plasmid DNA to relaxed [(R) nicked circular,
Form II] and linear [(L) Form III] forms with dose dependent kinetics in the standard DNA
nicking assay (Fig. 1b). This conversion was not affected by the location (amino- or
carboxy-terminus) of the His6-tag. One μg of recombinant CdtB-His6 converted 95% of 1
μg of supercoiled plasmid DNA to relaxed or linear forms in 1 hour at 37°C. The
substitution mutant CdtBH160A (from pMUT160cdtB in Table 1) had no effect on
supercoiled plasmid DNA confirming that recombinant CdtB-His6 preparations were not
contaminated with E. coli nucleases (data not shown). In comparison, 0.1 ng bovine DNase I
converted 100% of 1 μg of supercoiled plasmid DNA to relaxed form in 1 hour at 37°C
(Fig. 1c). A ten-fold higher concentration of DNase I converted 98% of 1 μg of supercoiled
DNA to linear form and a 100-fold higher concentration of the nuclease completely digested
the DNA into small fragments. Based on these results the specific activity of recombinant
CdtB-His6 was estimated to be as much as 103-fold lower than that of bovine DNase I.
Maximum conversion of supercoiled DNA to relaxed and linear forms was obtained with
either 50 mM MgCl2, CaCl2 or MnCl2 (Fig. 1d). Reactions containing CaCl2 consistently
failed to go to completion. CdtB-His6 nuclease activity was inhibited by MgCl2, CaCl2 and
MnCl2 when the cation concentrations were greater than 150–200 mM. No conversion of
supercoiled DNA was observed at any divalent cation concentration in the absence of CdtB
and various combinations of the cations (50 mM of each) did not affect digestion patterns
relative to those obtained with the individual cations. A time course of digestion with 50
mM MgCl2 in the reaction established that 1 μg of CdtB-His6 completely converted 1 μg of
supercoiled DNA to relaxed and linear forms in 1 hour at 37°C (data not shown). Incubation
times of 2 hours or greater generated more linear form DNA. Thus, CdtB-His requires either
Mg++, Ca++ or Mn++ at an individual or combined concentration of 50 mM for optimum
activity. This is a 10-fold higher concentration than that required for optimum DNase I
activity (Price, 1975). The standard in vitro DNase activity assay used in all subsequent
experiments contained 50 mM MgCl2.

FEMS Microbiol Lett. Author manuscript; available in PMC 2012 December 17.
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Cdt-B-His6 retained greater than 90% of its DNA nicking activity following incubation for 5
min in a boiling water bath (data not shown). There was a loss of virtually all enzymatic
activity after heating for 10 min. In contrast, bovine DNase I DNA nicking activity was less
than 50% of the control after 5 min of heating. The DNA nicking activity of both enzymes
was significantly more heat stable than the double-strand cleavage activity.
Characterization of cdtB/DNase I and DNase I/cdtB chimeric genes and gene products
Notable differences between the biochemical properties of CdtB and DNase I suggested that
a genetic strategy based on the analysis of the products of chimeric genes could be used to
further examine functional similarities and differences between the two proteins. This
approach was facilitated by the presence of a unique SphI restriction endonuclease cleavage
site at approximately the mid-point of both wild-type gene sequences. Using each half of the
CdtB-His6 and human DNase I gene sequences two genetic constructs, pETBDN2 and
pETDNB1 containing the chimeric ORFs cdtB/DNase I and DNase I/cdtB, respectively
(Table 1) were made. Both ORFs were placed immediately downstream from a highly
efficient, inducible promoter and contained six or seven histidine codons in frame at the 3'end of each sequence.
Two active site catalytic histidines are conserved in CdtB from A. actinomycetemcomitans
and bovine DNase I (Fig. 2a). A deduced amino acid sequence alignment showed that both
hybrid gene products contain the two histidines [residues H160/157 and H278/271 in CdtB/
DNase I and DNase I/CdtB, respectively] (Fig. 2b). Computer modeling indicated that only
the CdtB/DNase I hybrid protein maintained a folded structure similar to those of native
CdtB and DNase I (Fig. 2c). However, both hybrid proteins exhibited optimum in vitro
supercoiled DNA nicking activity in the presence of 50 mM MgCl2. The DNA nicking
activity of CdtB/DNase I was not affected after incubation in a boiling water bath for 5 min
but there was a significant reduction in the DNA nicking activity of DNase I/CdtB after the
same treatment ((data not shown). In contrast to bovine DNase I, G-actin had no effect on
the ability of CdtB-His6 and CdtB/DNase I to convert supercoiled DNA to relaxed and
linear forms. Conversely, actin inhibited the DNA nicking activity of DNase I/CdtB. The
results of these assays demonstrated that the amino terminal portions of CdtB and DNase I
carry the biochemical properties of thermostability and actin binding, respectively.
Subunit assembly of cdtB/DNase I and DNase I/cdtB hybrid proteins
A property specific to CdtB is the ability to bind the CdtA and CdtC subunits to form a
biologically active heterotrimer. CdtB/DNase I but not DNase I/CdtB bound to CdtA-CdtC
heterodimer at concentrations comparable to CdtB-His6 (Fig. 3a). Both the CdtB-His6
control and CdtB/DNase I hybrid proteins reached saturation binding at approximately 3–4
μg per 4.0 μg of CdtA-His6 and 3.5 μg of CdtC-His6. Consistent with these results, CdtB/
DNase I but not DNase I/CdtB, formed a heterotrimer complex in the differential dialysis
assay (Fig. 3a; inset). In addition, CdtB/DNase I but not DNase I/CdtB bound
stoichiometrically to CdtA and CdtC (Fig. 3b) and reconstituted heterotrimer preparations
containing the CdtB/DNase I hybrid protein failed to convert supercoiled DNA to linear and
relaxed forms (Fig. 3b; inset). Although these four independent assays established that the
CdtB/DNase I hybrid protein formed a heterotrimer, this complex failed to inhibit the
proliferation and cell cycle progression of CHO cells.
Effect of targeted amino acid substitutions on the DNA nicking and subunit binding
activities of CdtB/DNase I
Since the DNase I/CdtB hybrid protein failed to bind CdtA and CdtC (Fig. 3), lacked a key
domain for nuclear localization (Fig. 2b) and appeared to have an unfolded conformation in
computer models (data not shown) it was not studied further. Single amino acid substitutions
FEMS Microbiol Lett. Author manuscript; available in PMC 2012 December 17.
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were sequentially made in the CdtB/DNase I hybrid protein based on the results from
mutagenesis studies of the bovine and human forms of the DNase I gene (Pan et al., 1998).
Substitutions G55R, S99Y and V134R added DNA contact residues, L63E added a metal
ion binding residue and R100E added a residue that hydrogen bonds to the catalytic H160 in
DNase I.(Fig. 2b and Table 1). Five hundred ng of the final mutated hybrid gene product,
CdtB/DNase Imut5 (clone pETBDN2–5), converted 100% of 1 μg of supercoiled DNA to
relaxed and linear forms under standard assay conditions resulting in an approximately 1.4fold increase in specific activity relative to CdtB-His6 and CdtB/DNase I (Fig. 4 and inset
B). CdtB/DNase Imut5 exhibited classical first-order kinetics (inset A).
Two regions in CdtB considered to be important for subunit assembly are the α-helix H1
(residues N41-S54) and a large loop (residues L261-S272) which are predicted to bind to
CdtC and CdtA, respectively (Hu et al., 2006). Since the CdtB/DNase I hybrid contains the
former but not the latter motif the large loop sequence LMLNQLRSQIT (residues 261–272
in Fig. 2b) was added to CdtB/DNase Imut5. However, this modification failed to improve
the ability of the hybrid protein to form an active heterotrimer with CdtA and CdtC.

Discussion
A number of studies have shown that the CdtB subunit of the Cdt promotes inhibition of cell
proliferation of epithelial cells through a DNA-damaging mechanism. However, questions
remain about the mechanism of action of CdtB based on its phylogenetic (Hofmann et al.,
2000) and structural (Dlakic, 2000) connection to a wide range of eukaryotic
phosphohydrolases. Theoretically, each of these classes of enzyme are capable of inducing
cell cycle arrest through a variety of mechanisms all requiring Mg2+-dependent hydrolysis
of phosphate (Mock & Ullmann, 1993). The largest body of empirical evidence supports an
in vivo endonuclease type mechanism of DNA damage (Oswald et al., 2005). Indeed, it has
been reported that the cdtB gene product from E. coli (Elwell & Dreyfus, 2000) and
Helicobacter hepaticus (Dassanayake et al., 2005) have in vitro biochemical properties
consistent with a Mg2+-dependent nuclease. We found that although both the A.
actinomycetemcomitans CdtB and mammalian DNase I exhibit in vitro DNA nicking
activity there were significant differences such that CdtB requires a 10-fold increase in
divalent cation concentration to optimally convert supercoiled to relaxed form DNA, is more
heat stable than DNase I, is not inactivated by actin and has a relatively lower specific
activity. These differences are not surprising since the cdtB gene has evolved as part of a
prokaryotic cytotoxin and, as such, would not be expected to be identical to a typical
endonuclease.
Obtaining functional chimeras of the cdtB and human DNase I genes strongly supports the
close relationship between the two gene products. The chimeric cdtB-DNase I genes were
expressed in E. coli and the gene products exhibited nuclease activity, in vitro, comparable
to that of CdtB. The fact that these artificial prokaryotic/eukaryotic gene constructs were
expressed by E. coli and satisfied very stringent requirements to maintain a specific
enzymatic activity provides compelling and novel evidence that the cdtB gene has evolved
as an atypical divalent cation-dependent nuclease with remarkable similarities to
mammalian DNase I. There appears to be a significantly weaker relationship between other
phosphohydrolases and CdtB. For example, multiple large gaps have to be inserted to force
an alignment between the deduced amino acid sequences of phosphatidylinositol 3,4,5triphosphate phosphatase and CdtB (Shenker et al., 2007). A typical CdtB and human
DNase I alignment requires only a few relatively small gaps (see Fig. 2b).
Even though the CdtB/DNase I hybrid protein exhibited in vitro DNA nicking/cutting
activity and appeared to form a heterotrimer with CdtA and CdtC, as determined by four
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independent assays, it failed to form a biologically active heterotoxin. The hybrid protein
may be defective in either the ability to enter cells or to migrate to the cell nucleus because it
has a non-native conformation. Additional details about the cell intoxication process will be
required to design experiments to examine these possibilities. However, the successful
construction of the chimeric genes indicates that there may be significant potential to exploit
the functional relationship between CdtB and human DNase I to genetically engineer novel
therapeutic reagents that take advantage of the most desirable features of each native
protein. DNase I has therapeutic applications including the treatment of wounds and ulcers,
bronchitis, inflammatory conditions, herpes infection and cystic fibrosis (Lloyd, 1968; Shak
et al., 1990). Most notably, DNase I has a significantly more potent DNA cutting/nicking
activity than CdtB. In contrast, CdtB can enter cells and translocate to the nucleus. We
found that immortalized epitheloid cell lines, including HeLa, KB, HEp-2 (DiRienzo et al.,
2002) and GMSM-K (Kanno et al., 2005), as well as cells from oral squamous cell
carcinomas (manuscript in preparation), are particularly sensitive to the cytotoxic effects of
the Cdt. Cells of mesenchymal and ectomesenchymal origin, such as human periodontal
ligament fibroblasts, cementoblasts and osteoblasts are resistant (Kang et al., 2005; Kanno et
al., 2005; unpublished data). Since the effects of the Cdt are most pronounced on rapidly
proliferating epitheloid cells the toxin has potential anti-cancer applications. Our approach,
initiated in this study, is to develop a genetically engineered CdtB/DNase I chimera to
attempt to increase the DNA-damaging activity of the toxin while maintaining a native
mechanism for delivery to the cell nucleus.
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Fig. 1.

(a) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of affinity purified
recombinant A. actinomycetemcomitans CdtB-His6. The gel is stained with Coomassie
Brilliant Blue. (b) Dose response kinetics of the conversion of supercoiled (S) plasmid DNA
to relaxed (R) and linear (L) forms by CdtB-His6. Agarose gel stained with ethidium
bromide. The activity of CdtB labeled with a histidine tag at the amino terminal end of the
protein is compared at the highest concentration (1 μg/1 μg of DNA) of CdtB-His6 tested.
(c) Dose response kinetics of the activity of bovine DNase I. (d) DNA nicking assay
containing increasing concentrations of either MgCl2 (top panel), CaCl2 (middle panel) or
MnCl2 (bottom panel) in the standard reaction buffer. Supercoiled (S), relaxed (R) and linear
(L) forms of DNA were quantified by densitometry of ethidium bromide stained agarose
gels (insets). The data shown is representative of several repeat experiments.
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Fig. 2.

(a) Computer models of the A. actinomycetemcomitans CdtB (as part of the Cdt
heterotrimer) and bovine DNase I. (b) Sequence alignment of the four His-tagged constructs.
Conserved and identical residues are marked by dots and asterisks, respectively. The blue
and orange arrows mark the gene fusion position and predicted signal sequence cleavage
sites, respectively. Amino acid substitutions are marked in green and predicted functional
domains are in red. Location of the nuclear localization signal (NLS) and information about
the location of functional residues in DNase I was from Nishikubo et al. (2003) and Pan et
al. (1998), respectively. Disulfides in DNase I are designated by brackets. (c) Theoretical
model of the CdtB/DNase I hybrid protein construct. The CdtB (amino-terminal half) and
DNase I (carboxy-terminal half) portions of the hybrid protein are shown in orange and
magenta, respectively. The amino- (N) and carboxy (C)-termini are labeled.
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Fig. 3.

(a) Saturation binding kinetics of the two hybrid proteins were compared to that of CdtBHis6. The same proteins were incubated with wild-type CdtA and CdtC in refolding buffer
and subjected to differential dialysis. The reconstituted samples were examined before (BD)
and after (AD) dialysis on a western blot (inset). (b) The stoichiometric binding of the two
hybrid proteins to wild-type CdtA and CdtC immobilized on thyroglobulin was examined by
ELISA. Numbers above the columns are absorbance ratios calculated as described in
Methods. The hybrid proteins, and CdtB-His6 as a control, were mixed with wild-type CdtA
and CdtC, as in the differential dialysis experiment in the inset in panel A, and the
reconstituted samples assayed for DNA nicking activity (inset). The reaction examined in
the first lane contained non-complexed CdtB-His6. Abbreviations are the same as in the
legend for Fig. 1. Experiments were performed a minimum of three times. Mean values and
standard deviations were plotted where appropriate.
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Fig. 4.

Nuclease activity of CdtB/DNase Imut5 was compared to that of CdtB-His6 and the original
CdtB/DNase I construct. The data is expressed as a percentage of the supercoiled (S) form
DNA remaining after the reaction. These values were obtained by densitometry of ethidium
bromide stained agarose gels (inset A). Semilogarithmic plot of the log of the substrate
concentration [S] versus time of the reaction (expressed in minutes) for CdtB/DNase Imut5
(inset B). [S] represents the amount of S-form DNA obtained by densitometry of the agarose
gel in the inset). The control lacked enzyme. The data shown is representative of several
repeat experiments.
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Table 1

Plasmids used in this study
Plasmid

Features

Source or reference

GC-C0001

human DNase I gene in pReceiver-B02

GeneCopoeia

pJD1

DNase I gene containing 6 His codons at 3'-end in pETBlue2

This study

pJDB7

cdtB gene containing 6 His codons at 3'-end in pET15b

Cao et al., 2005

pMUT160cdtB

pJDB7 with substitution H160A

This study

pETDN1

human DNase I gene containing 7 His codons at 3'-end in pET15b

This study

pBDN1

cdtB/DNase I chimeric gene containing 6 His codons at 3'-end in pETBlue2

This study

pETBDN2

cdtB/DNase I chimeric gene containing 7 His codons at 3'-end in pET15b

This study

pETDNB1

DNase I/cdtB chimeric gene containing 6 His codons at 3'-end in pET15b

This study

pETBDN2–1

pETBDN2 with substitutions S99Y and R100E

This study

pETBDN2–2

pETBDN2–1 with substitution L62E

This study

pETBDN2–4

pETBDN2–3 with substitution G55R

This study

pETBDN2–5

pETBDN2−4 with substitution V134R

This study

pETBDN2–5LL

pETBDN2–5 with substitution N265–I275 to L265–T275

This study

pETBlue2

Cloning vector

Novagen

pET15b

Cloning vector

Novagen
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Table 2

Primers used in this study
Name

Sequence*

N-DNase-F

5'-AAATTACCATGGTGAGGGGAATGAAGC-3'

X-DNase-R

5'-TAATATTCTCGAGCTTCAGCATCACCT-3'

N-cdtB-F

5'-AAACGCGCCATGGAGTGGGTAAAGCAAT-3'

S-cdtB-R

5'-GGCCAAAGCATGCACTGTAAAA-3'

NdeI-His

5'-ATTAACTTAATTACATATGGTGGTGGTGGTGGTGGTG-3'

DNaseI-His

5'-TTTGGATCCGTGGTGGTGGTGGTGGTGCTTCAGCATCAC-3'

H160Afor

5'-ACTGATGTATTTTTTACAGTGGCTGCTTTGGCCACAGGTGG-3'

H160Arev

5'-CCACCTGTGGCCAAAGCAGCCACTGTAAAAAATACATCAGT-3'

CdtB-DN-S99Y, R100E-F

5'-GAGGAATATACCTGGAATTTAGGTACTCGCTATGAGCCAAATATGGTCTATATTTATT-3'

CdtB-DN-S99Y, R100E-R

5'-AATAAATATAGACCATATTTGGCTCATAGCGAGTACCTAAATTCCAGGTATATTCCTC-3'

CdtB-DN-L62E-F

5'-AATTATTATCGCGAGAACAAGGTGCAGATATTGAGATGGTACAAGAAGC-3'

CdtB-DN-L62E-R

5'-GCTTCTTGTACCATCTCAATATCTGCACCTTGTTCTCGCGATAATAATT-3'

CdtB-DN-G55R-F

5'-AATGTGCGCCAATTATTATCGAGGGAACAAGGTGC-3'

CdtB-DN-G55R-R

5'-GCACCTTGTTCCCTCGATAATAATTGGCGCACATT-3'

CdtB-DN-V134R-F

5'-CAAGCCGATGAAGCTTTTATCCGACATTCTGATTCTTCTGTGCT-3'

CdtB-DN-V134R-R

5'-AGCACAGAAGAATCAGAATGTCGGATAAAAGCTTCATCGGCTTG-3'

Loop-F

5' -CGCTCACAAATTACAAGTGACCACTATCCAG-3'

Loop-R

5' -TAACTGATTTAACATTAAGGCAGCCTGGAAG-3'

*

Underlined bases show the NcoI (CCATGG), XhoI (CTCGAG). SphI (GCATGC), NdeI (CATATG) and BamHI (GGATCC) restriction
endonuclease cleavage sites. Bold type marks the changed codon(s).
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